Transcriptomics

Dataset Information

0

Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling [Affymetrix]


ABSTRACT: In the field of MDS and on bone marrow mononuclear cells , we search for a signature which predict the response to Lenalidomide treatment. This transcriptome study appended to the GFM-LEN-EPO-2008 clinical trial reports a predictive signature of response to lenalidomide and a unique immune response signature after treatment.

ORGANISM(S): Homo sapiens

PROVIDER: GSE102976 | GEO | 2017/08/24

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-01-28 | GSE126265 | GEO
| EGAS00001004113 | EGA
2024-04-18 | GSE245452 | GEO
| PRJNA430776 | ENA
2016-06-08 | GSE82235 | GEO
2013-07-01 | GSE35656 | GEO
2013-07-01 | E-GEOD-35656 | biostudies-arrayexpress
| S-EPMC4853910 | biostudies-literature
| PRJNA521440 | ENA